Literature DB >> 16776692

Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients.

G Sandrini1, P Rossi, I Milanov, M Serrao, A P Cecchini, G Nappi.   

Abstract

The aim of this study was to evaluate the function of pain modulating systems subserving diffuse noxious inhibitory controls (DNICs) in primary headaches. DNICs were examined in 24 migraineurs, 17 patients with chronic tension-type headache (CTTH) and 20 healthy subjects by means of nociceptive flexion RIII reflex and the cold pressor test (CPT) as heterotopic noxious conditioning stimulation (HNCS). The subjective pain thresholds (Tp) and the RIII reflex threshold (Tr) were significantly lower in CTTH vs. controls. In controls a significant inhibition of the RIII reflex was observed during the CPT (-30%, P < 0.05). Conversely, migraine and CTTH patients showed facilitation (+31%, P < 0.05 and +40%, P < 0.01, respectively) of the RIII reflex during the HNCS. This study demonstrates a dysfunction in systems subserving DNICs in both migraine and CTTH. Impairment of endogenous supraspinal pain modulation systems may contribute to the development and/or maintenance of central sensitization in primary headaches.

Entities:  

Mesh:

Year:  2006        PMID: 16776692     DOI: 10.1111/j.1468-2982.2006.01130.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  54 in total

1.  Reliability of the conditioned pain modulation paradigm to assess endogenous inhibitory pain pathways.

Authors:  Gwyn N Lewis; Luke Heales; David A Rice; Keith Rome; Peter J McNair
Journal:  Pain Res Manag       Date:  2012 Mar-Apr       Impact factor: 3.037

Review 2.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

3.  Reliability of temporal summation and diffuse noxious inhibitory control.

Authors:  S Cathcart; A H Winefield; P Rolan; K Lushington
Journal:  Pain Res Manag       Date:  2009 Nov-Dec       Impact factor: 3.037

4.  Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism.

Authors:  Ruth Defrin; Miri Riabinin; Yelena Feingold; Shaul Schreiber; Chaim G Pick
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

5.  Dexamethasone-suppressed Salivary Cortisol and Pain Sensitivity in Female Twins.

Authors:  Kathryn M Godfrey; Matthew Herbert; Eric Strachan; Sheeva Mostoufi; Leslie J Crofford; Dedra Buchwald; Brian Poeschla; Annemarie Succop; Niloofar Afari
Journal:  Clin J Pain       Date:  2017-03       Impact factor: 3.442

Review 6.  The role of muscles in tension-type headache.

Authors:  Lars Bendtsen; César Fernández-de-la-Peñas
Journal:  Curr Pain Headache Rep       Date:  2011-12

7.  In child and adult migraineurs the somatosensory cortex stands out … again: An arterial spin labeling investigation.

Authors:  Andrew M Youssef; Allison Ludwick; Sophie L Wilcox; Alyssa Lebel; Ke Peng; Elisabeth Colon; Amy Danehy; Rami Burstein; Lino Becerra; David Borsook
Journal:  Hum Brain Mapp       Date:  2017-05-31       Impact factor: 5.038

8.  Investigation of central pain processing in postoperative shoulder pain and disability.

Authors:  Carolina Valencia; Roger B Fillingim; Mark Bishop; Samuel S Wu; Thomas W Wright; Michael Moser; Kevin Farmer; Steven Z George
Journal:  Clin J Pain       Date:  2014-09       Impact factor: 3.442

9.  Lack of cold pressor test-induced effect on visual-evoked potentials in migraine.

Authors:  Gianluca Coppola; Antonio Currà; Mariano Serrao; Cherubino Di Lorenzo; Manuela Gorini; Elisa Porretta; Alessia Alibardi; Vincenzo Parisi; Francesco Pierelli
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

Review 10.  Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and Clinical Pain.

Authors:  Janie Damien; Luana Colloca; Carmen-Édith Bellei-Rodriguez; Serge Marchand
Journal:  Int Rev Neurobiol       Date:  2018-08-14       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.